Exonics Therapeutics
Watertown, US · Founded 2016 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
JR
John RippleExecutive
JG
Jesper GromadaNamed on SEC filing
HJ
H. James MageeNamed on SEC filing
RP
Roger PerlmutterNamed on SEC filing
Board
JK
DG
David GoeddelBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$22M disclosed across 1 round · 2017
▶$22MraisedNov 2018 · 2 investors · BiotechnologyRule 506(b)
▶$22MraisedNov 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jesper GromadaExecutive Officer
- H. James MageeExecutive Officer
- JeenJoo KangDirector
- David GoeddelDirector
- Roger PerlmutterDirector
- John RippleExecutive Officer, Director
- Offering amount
- $42M
- Amount sold
- $22M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Exonics Therapeutics's investors?
- Exonics Therapeutics's investors include The Column Group.
- How much funding has Exonics Therapeutics raised?
- Exonics Therapeutics has disclosed $22M raised across 1 round.
- Where is Exonics Therapeutics headquartered?
- Exonics Therapeutics is headquartered in Watertown, US.